Gyala Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). (NCT07471789) | Gyala Therapeutics | 2026-02-04 |
Track Gyala Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.